WLWeihai Liu

Weihai Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Weihai Liu has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Jingnan Shen

    Department of Musculoskeletal Oncology, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China

    2 shared publications
  • Junqiang Yin

    Department of Musculoskeletal Oncology, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China

    2 shared publications
  • Changye Zou

    The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China

    1 shared publication
  • Fei Wu

    Department of Musculoskeletal Oncology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

    1 shared publication
  • Guangmei Yan

    Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China

    1 shared publication
  • Guanyu Huang

    Department of Musculoskeletal Oncology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

    1 shared publication

Latest Publications

  • Open Access

    Alphavirus M1 disrupts super-enhancer-driven oncogenic transcription via non-structural protein NSP2 in osteosarcoma

    by Jiajun Zhang, Lifeng Yin, Qianqian Han, Yuanyuan Li, Fei Wu, Shanyu Huang, Jiayu Zhang, Yiwei Fu, Guanyu Huang, Yu Xu, et al.

    Oncolytic virotherapy has shown promise for various cancers, but its application in osteosarcoma (OS) remains underexplored. This study provides evidence that M1, a natural Getah-like alphavirus, exerts oncolytic activity against OS. We demonstrate that OS cells exhibit heightened sensitivity to M1 infection, with its anti-tumor effects not solely dependent on the canonical ER stress-induced apoptosis. Proteomic and ChIP-seq analyses show the DNA-directed RNA polymerase II subunit RPB1 contributes to oncogenic super-enhancer activity and serves as a direct target of M1-mediated regulation. The oncolytic potency correlated positively with the transcriptional dependency on RPB1 within super-enhancer regions. Mechanistically, the viral non-structural protein NSP2 disrupts super-enhancer activity by recruiting the CUL2-RBX1-ELOC complex, which triggers K63-linked ubiquitination and degradation of RPB1. Together, these findings uncover a previously unrecognized mechanism underlying M1 activity in osteosarcoma, support further preclinical evaluation of M1 in this setting, and identify RPB1 as a candidate biomarker for virotherapy response.

  • Open Access

    The Application of Orthopedic Surgical Robot‐Assisted Technology in Various Clinical Scenarios Involving Bone Tumors

    by Hanxiao Yin, Yiwei Fu, Xirenijiang Yikemu, Weihai Liu, Changye Zou, Xianbiao Xie, Zhiqiang Zhao, Puyi Sheng, Jingnan Shen, Junqiang Yin

    Objectives: Over the past three decades, orthopedic surgical robots have experienced rapid advancements. This study, a case series, aimed to investigate the effectiveness, limitations, and technical improvements associated with the application of robots in the surgical treatment of bone tumors. Methods: From November 2021 to October 2023, 54 patients with bone tumors who provided consent for robot‐assisted surgery were included. Patients were divided into three groups based on specific objectives: robot‐assisted path planning, pedicle screw insertion, and intraoperative real‐time navigation‐assisted tumor resection. Perioperative conditions were meticulously recorded for all patients, including intraoperative blood loss, operation duration, postoperative complications, and tumor diameter. Results: Nineteen patients underwent robot‐assisted tissue biopsies, and pathological examinations confirmed a positive rate of 84.21%. Among the 21 patients undergoing robot‐assisted pedicle screw placement, surgical planning was executed with high accuracy. Twenty patients undergoing robot‐assisted lesion excision achieved precise resection of the tumor‐affected bone segments as planned preoperatively, and no secondary osteotomies were required. No perioperative complications related to the use of robots were observed in the 54 patients. To address the limitation of orthopedic robots in differentiating soft tissues, we integrated ultrasound technology and the da Vinci robot. Additionally, patient‐specific cutting guides were utilized to compensate for the prolonged operation time associated with planar planning using orthopedic robots. Conclusions: Robot‐assisted technology facilitates the precise planning of the surgical path and determination of the osteotomy plane. The integration of orthopedic robots with intraoperative ultrasound or Da Vinci robots can potentially further ensure the safety of bone tumor surgery while maintaining its accuracy, thereby minimizing the risk of complications associated with surgical procedures. Furthermore, this technology combined with patient‐specific cutting guides may be conducive to reducing operation time.